Reply to "Modulatory Effects of a Subinhibitory Concentration of Clindamycin in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains of Sequence Type 30"

Antimicrob Agents Chemother. 2017 Feb 23;61(3):e02386-16. doi: 10.1128/AAC.02386-16. Print 2017 Mar.

Authors

Katrin Schilcher¹, Vanina Dengler Haunreiter², Annelies S Zinkernagel¹

Affiliations

¹ Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland katrin.schilcher@usz.ch annelies.zinkernagel@usz.ch.
² Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Bacterial Agents
Clindamycin*
Community-Acquired Infections
Humans
Methicillin
Methicillin-Resistant Staphylococcus aureus*
Microbial Sensitivity Tests
Staphylococcal Infections

Substances

Anti-Bacterial Agents
Clindamycin
Methicillin